Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
05 04 2019
05 04 2019
Historique:
entrez:
20
4
2019
pubmed:
20
4
2019
medline:
14
2
2020
Statut:
epublish
Résumé
Asia is home to the largest diabetic populations in the world. However, limited studies have quantified the association of diabetes with all-cause and cause-specific mortality in Asian populations. To evaluate the association of diabetes with all-cause and cause-specific mortality in Asia and to investigate potential effect modifications of the diabetes-mortality associations by participants' age, sex, education level, body mass index, and smoking status. This pooled analysis incorporated individual participant data from 22 prospective cohort studies of the Asia Cohort Consortium conducted between 1963 and 2006. A total of 1 002 551 Asian individuals (from mainland China, Japan, South Korea, Singapore, Taiwan, India, and Bangladesh) were followed up for more than 3 years. Cohort-specific hazard ratios and 95% confidence intervals for all-cause and cause-specific mortality were estimated using Cox regression models and then pooled using random-effects meta-analysis. Analysis was conducted between January 10, 2018, and August 31, 2018. Doctor-diagnosed diabetes, age, sex, education level, body mass index, and smoking status. All-cause and cause-specific mortality. Of 1 002 551 participants (518 537 [51.7%] female; median [range] age, 54.0 [30.0-98.0] years), 148 868 deaths were ascertained during a median (range) follow-up of 12.6 (3.0-38.9) years. The overall prevalence of diabetes reported at baseline was 4.8% for men and 3.6% for women. Patients with diabetes had a 1.89-fold risk of all-cause death compared with patients without diabetes (hazard ratio [HR], 1.89; 95% CI, 1.74-2.04), with the highest relative risk of death due to diabetes itself (HR, 22.8; 95% CI, 18.5-28.1), followed by renal disease (HR, 3.08; 95% CI, 2.50-3.78), coronary heart disease (HR, 2.57; 95% CI, 2.19-3.02), and ischemic stroke (HR, 2.15; 95% CI, 1.85-2.51). The adverse diabetes-mortality associations were more evident among women (HR, 2.09; 95% CI, 1.89-2.32) than among men (HR, 1.74; 95% CI, 1.62-1.88) (P for interaction < .001) and more evident among adults aged 30 to 49 years (HR, 2.43; 95% CI, 2.08-2.84) than among adults aged 70 years and older (HR, 1.51; 95% CI, 1.40-1.62) (P for interaction < .001). A similar pattern of association was found between diabetes and cause-specific mortality, with significant variations noted by sex and age. This study found that diabetes was associated with increased risk of death from several diseases among Asian populations. Development and implementation of diabetes management programs are urgently needed to reduce the burden of diabetes in Asia.
Identifiants
pubmed: 31002328
pii: 2730789
doi: 10.1001/jamanetworkopen.2019.2696
pmc: PMC6481439
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e192696Subventions
Organisme : NCI NIH HHS
ID : R01 CA055069
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182876
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072507
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA043092
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA082729
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA173640
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA070867
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA080205
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA053890
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182910
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA144034
Pays : United States
Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Am J Epidemiol. 2004 Jun 15;159(12):1160-7
pubmed: 15191933
JAMA. 2017 Jan 17;317(3):280-289
pubmed: 28114552
Diabetes Care. 2011 Jun;34(6):1249-57
pubmed: 21617109
Lancet. 2006 Nov 11;368(9548):1681-8
pubmed: 17098087
Diabet Med. 2006 Aug;23(8):857-66
pubmed: 16911623
Nutr Metab Cardiovasc Dis. 2009 Mar;19(3):190-7
pubmed: 18774701
Lancet. 2010 Jan 30;375(9712):408-18
pubmed: 19875164
Lancet. 2014 Jun 7;383(9933):1973-80
pubmed: 24613026
Diabet Med. 2018 Oct;35(10):1345-1354
pubmed: 29851428
Exp Mol Med. 2016 Mar 11;48:e219
pubmed: 26964835
Diabetologia. 2014 Aug;57(8):1542-51
pubmed: 24859435
N Engl J Med. 2016 Nov 17;375(20):1961-1971
pubmed: 27959614
Int J Diabetol Vasc Dis Res. 2015;2015(Suppl 1):
pubmed: 27583258
N Engl J Med. 2011 Mar 03;364(9):829-841
pubmed: 21366474
N Engl J Med. 2015 Oct 29;373(18):1720-32
pubmed: 26510021
Am J Epidemiol. 2003 Sep 15;158(6):543-52
pubmed: 12965880
Diabetes Care. 2012 Sep;35(9):1835-44
pubmed: 22699290
Stat Med. 2017 Feb 28;36(5):772-789
pubmed: 27910122
Diabetes Care. 2016 Mar;39(3):472-85
pubmed: 26908931
N Engl J Med. 2011 Feb 24;364(8):719-29
pubmed: 21345101
JAMA. 2005 Jan 12;293(2):194-202
pubmed: 15644546
Lancet Diabetes Endocrinol. 2018 Jul;6(7):538-546
pubmed: 29752194
Diabetologia. 2017 Jun;60(6):1022-1032
pubmed: 28265721
Stat Med. 2017 Feb 28;36(5):855-875
pubmed: 27747915
Diabetes Res Clin Pract. 1999 Jan;43(1):67-74
pubmed: 10199590
Lancet. 2011 Oct 1;378(9798):1231-43
pubmed: 21872920
Diabet Med. 2005 Mar;22(3):323-31
pubmed: 15717882
Environ Health Perspect. 2010 Sep;118(9):1299-305
pubmed: 20813654
PLoS One. 2011;6(6):e19930
pubmed: 21731609
Curr Diab Rep. 2018 Apr 18;18(6):33
pubmed: 29671082
Ann Oncol. 2011 Mar;22(3):730-8
pubmed: 20705912
Diabetes Care. 2016 Nov;39(11):1987-1995
pubmed: 27493134
Diabetes Care. 2003 Nov;26(11):2999-3005
pubmed: 14578230
Diabetes Care. 2003 Feb;26(2):360-6
pubmed: 12547863